BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19931308)

  • 1. Depression as an evolutionary adaptation: anatomical organisation around the third ventricle.
    Hendrie CA; Pickles AR
    Med Hypotheses; 2010 Apr; 74(4):735-40. PubMed ID: 19931308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression as an evolutionary adaptation: implications for the development of preclinical models.
    Hendrie CA; Pickles AR
    Med Hypotheses; 2009 Mar; 72(3):342-7. PubMed ID: 19153014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target.
    Lader M
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):743-55. PubMed ID: 17624740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal and pharmacological manipulation of the circadian clock: recent developments and future strategies.
    Richardson G; Tate B
    Sleep; 2000 May; 23 Suppl 3():S77-85. PubMed ID: 10809190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nicotine as an antidepressant and regulator of sleep in subjects with depression].
    Vieyra-Reyes P; Venebra-Muñoz A; Rivas-Santiago B; García-García F
    Rev Neurol; 2009 Dec 16-31; 49(12):661-7. PubMed ID: 20013719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enhancement of social functioning as a therapeutic principle in the management of depression.
    Healy D; McMonagle T
    J Psychopharmacol; 1997; 11(4 Suppl):S25-31. PubMed ID: 9438230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with antidepressant use in depressed and non-depressed community-dwelling elderly: the three-city study.
    Soudry A; Dufouil C; Ritchie K; Dartigues JF; Tzourio C; Alpérovitch A
    Int J Geriatr Psychiatry; 2008 Mar; 23(3):324-30. PubMed ID: 17907265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological models of depression: effect of antidepressants on sleep].
    Viot-Blanc V
    Encephale; 1995 Dec; 21 Spec No 7():35-40. PubMed ID: 8929677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Darwinian models of depression: a review of evolutionary accounts of mood and mood disorders.
    Allen NB; Badcock PB
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):815-26. PubMed ID: 16647176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Foundations of the new phylogenetics].
    Pavlinov IIa
    Zh Obshch Biol; 2004; 65(4):334-66. PubMed ID: 15490579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1.
    Tsai SJ
    Med Hypotheses; 2008; 70(3):548-50. PubMed ID: 17703894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life: an important dimension in assessing the treatment of depression?
    Kennedy SH; Eisfeld BS; Cooke RG
    J Psychiatry Neurosci; 2001; 26 Suppl(Suppl):S23-8. PubMed ID: 11590966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of depression: are there any?
    O'Neil MF; Moore NA
    Hum Psychopharmacol; 2003 Jun; 18(4):239-54. PubMed ID: 12766928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.